Safer injection facility use and syringe sharing in injection drug users.
about
Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facilityThe law (and politics) of safe injection facilities in the United StatesThe cost-effectiveness of Vancouver's supervised injection facilitySummary of findings from the evaluation of a pilot medically supervised safer injecting facilityPotential community and public health impacts of medically supervised safer smoking facilities for crack cocaine usersEstimated drug overdose deaths averted by North America's first medically-supervised safer injection facilitySupervised injection facilities in Canada: past, present, and futureCorrelates of public support toward federal funding for harm reduction strategies.Public health and international drug policy.Amazing grace: Vancouver's supervised injection facility granted six-month lease on life.Structural factors associated with an increased risk of HIV and sexually transmitted infection transmission among street-involved youth.Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis.Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.Science and ideologyDeterminants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort studyThe association between residential eviction and syringe sharing among a prospective cohort of street-involved youthMitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facilityAssisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming.Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian CityAcceptability of a safer injection facility among injection drug users in San Francisco.An external evaluation of a peer-run outreach-based syringe exchange in Vancouver, CanadaA cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, CanadaSocial structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study.Vancouver's supervised injection facility challenges Canada's drug laws.An appeal to humanity: legal victory in favour of North America's only supervised injection facility: Insite.Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis.Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.Use of a medically supervised injection facility among street youthA dynamic social systems model for considering structural factors in HIV prevention and detection.Vancouver At Home: pragmatic randomized trials investigating Housing First for homeless and mentally ill adults.Disparities in the burden of HIV/AIDS in CanadaThe impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort studyThe role of harm reduction in controlling HIV among injecting drug users.A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada.Prevention of HIV infection among injection drug users in resource-limited settings.Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.Difficulty accessing syringes mediates the relationship between methamphetamine use and syringe sharing among young injection drug users.HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatmentDecreasing Impact of Requiring Assistance Injecting on HIV Incidence.Community viral load as a measure for assessment of HIV treatment as prevention
P2860
Q24649575-D5CF60CF-5C55-4ED1-9C53-551EC907B523Q24657290-049230F8-19D1-4546-8555-4A5AEDF930B6Q24657903-4E26AC1A-6E7A-4DFE-BAE1-718987F0230AQ24673390-ED203EDB-FD42-4B4F-BB09-3FFD62F26B79Q25257807-25556AC9-51AC-4455-BD6B-77921126675FQ28473764-32721B41-E81E-49C6-A84F-742451866259Q30234420-D54921FA-72FA-44AA-8C9A-26E220A351C3Q30279094-6ED89E53-C501-45E4-9AED-7FCAFB4CE265Q30377895-47777A5D-3615-40D3-9DC2-D88C9B3EE989Q30481221-7AEBEB74-0701-4079-B58C-13D9DEA0A0C5Q33398813-C761F223-E9F5-4BCA-917C-2253C0DAE022Q33453958-7A4BC765-CBCA-4B6B-81C8-8250A1C88878Q33488345-D835249B-116C-42BF-89B3-402D854B581CQ33572831-7B91F667-66DB-49B4-BE5C-DC4EF18CC0FFQ33599370-FA14C773-1124-474F-A3C0-58A74767E5D7Q33677230-128CCD23-2CFB-40EC-9EF2-C9A229DF1AE2Q33717043-E004A2A0-8BC0-47E7-A88C-CC75F45F59F5Q33797471-07F6D194-B63A-40B2-963C-53318BBEB16CQ33910606-2D96569A-0ECE-44D6-A770-66CE8031BB6DQ33912772-D41742A3-60BB-40F4-AE72-285EFB68F97DQ33959593-C73FDFD0-DDCC-4268-9A86-3907A323FF2BQ34009387-9B18D3BD-B1E8-4B70-A74D-E436E7A7F5CAQ34128484-01363593-AA00-4F3D-94AE-49D58F389BCBQ34142633-5FDB2B5C-944A-40EC-A594-2A012D0F927EQ34221599-4C25A1F3-F4E3-4D5E-BCC3-829C07DEA9F6Q34251466-54343800-2175-40FC-AD6F-2903B8A74974Q34315641-0DAC2503-CB91-4C83-B58B-AC63587F9F78Q34403782-AB166ABF-3CC3-4E1C-91CC-968246D71C6CQ34425735-356CD6C6-4C62-459E-ACCC-3DA896A5523BQ34493505-6924BDDB-ACD5-456F-ADC0-7D11C4DC009BQ34499532-809F69B9-325F-4CBE-8A72-A722F4F05375Q34582040-EAE040B2-4371-444B-BE2D-83CCF927B8C6Q34594511-0C716C09-1CFC-48ED-9DDD-3F0981C58AEDQ34611579-CED1CE21-2ED4-4C32-9ADA-BCE2B8624E3EQ35043964-CF81056F-462D-4626-8DC9-7C8A094B7E2CQ35127554-D1DCC0C2-074E-47F7-8DA5-649FAD9B1BFCQ35233571-E8DABB3D-F13B-4EA1-A4A4-C000CFF5EA2EQ35578532-E6FAFB99-7B78-4537-8E66-7ECF79394AFBQ35580003-2C0876D8-3B81-45CB-AB0A-C4330D02FADDQ35881546-7B4246FC-0D22-41D4-AE11-FDB11BB05F02
P2860
Safer injection facility use and syringe sharing in injection drug users.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Safer injection facility use and syringe sharing in injection drug users.
@ast
Safer injection facility use and syringe sharing in injection drug users.
@en
Safer injection facility use and syringe sharing in injection drug users.
@nl
type
label
Safer injection facility use and syringe sharing in injection drug users.
@ast
Safer injection facility use and syringe sharing in injection drug users.
@en
Safer injection facility use and syringe sharing in injection drug users.
@nl
prefLabel
Safer injection facility use and syringe sharing in injection drug users.
@ast
Safer injection facility use and syringe sharing in injection drug users.
@en
Safer injection facility use and syringe sharing in injection drug users.
@nl
P50
P1433
P1476
Safer injection facility use and syringe sharing in injection drug users
@en
P2093
P304
P356
10.1016/S0140-6736(05)66475-6
P407
P577
2005-07-01T00:00:00Z